Track the 옵티팜 stock price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares trade on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 옵티팜 has recorded 37 insider filings. The latest transaction was reported on 29 June 2026 (Purchase). Among the most active insiders: 김현일. All data is free.
37
Insider Decl.
n/a
Thresholds
€5,670
35 ops.
Buy Volume
n/a
1 ops.
Sell Volume
10Σ signal
Buys €5,670n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.